ESTI 2025: Lung cancer screening in Europe - Your questions. Our answers. Together towards a solution.

Europe is facing the major challenge of preparing the introduction of national lung cancer screening programs for high-risk patients - and MeVis is contributing its many years of experience!

With over 10 years of international experience in national lung cancer screening programs for early lung cancer detection and other national pilot projects - including in the UK, Canada, Australia, France and Norway - MeVis is a valued partner worldwide. We are happy to share this international expertise with you.

Visit us in Bergen from June 12 to 14, 2025 at the 31st annual meeting of the European Society of Thoracic Imaging (ESTI) and experience how Veolity, our comprehensive software solution for lung cancer screening, supports early detection efficiently, safely and with a view to the future.

Veolity combines state-of-the-art technology and an optimized workflow in a single platform:

  • AI-based CAD for precise round focus detection
  • Volumetric measurement & automatic growth analysis
  • Lung-RADS 2022 compliant reporting (modified version for Germany)
  • Fully automated workflows to reduce reading time

In addition to the radiology reporting software Veolity, MeVis offers a comprehensive solution for the introduction of screening programs, supporting you in all aspects of lung cancer screening - including patient management (partner application) and incidental findings.

We look forward to talking to you in person at our booth no. 11. Connect with our expert team, and experience radiology like never before.

Venue:

Grieghallen
Edvard Griegs Plass 1
5015 Bergen
Norway